SCHEMBL8307315

SCHEMBL8307315

O=C1SC(Cc2ccc(OCCON=Cc3ccncc3)cc2)C(=O)N1C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PPARG P37231 9/20 0.36
FFAR1 O14842 5/20 0.36
RARG P13631 1/20 0.34
RXRA P19793 1/20 0.34
CTSK P43235 1/20 0.33
ESR1 P03372 1/20 0.33
MAPT P10636 1/20 0.33
GLA P06280 1/20 0.33
ALDH1A1 P00352 1/20 0.33
ATM Q13315 1/20 0.32
TAAR1 Q96RJ0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8307312 1.00 PPARG (0.36) PPARGFFAR1RARGRXRACTSK
SCHEMBL8308951 0.94 PPARG (0.38) PPARGFFAR1RARGRXRACTSK
SCHEMBL8308949 0.94 PPARG (0.38) PPARGFFAR1RARGRXRACTSK
SCHEMBL8310110 0.91 TAAR1 (0.44) PPARGFFAR1RARGRXRATAAR1
SCHEMBL8310116 0.91 TAAR1 (0.44) PPARGFFAR1RARGRXRATAAR1
SCHEMBL8305071 0.90 PPARG (0.37) PPARGFFAR1RARGRXRACTSK
SCHEMBL8305072 0.90 PPARG (0.37) PPARGFFAR1RARGRXRACTSK
SCHEMBL8307958 0.89 PPARG (0.38) PPARGFFAR1RARGRXRACTSK
SCHEMBL8307959 0.89 PPARG (0.38) PPARGFFAR1RARGRXRACTSK
SCHEMBL8306092 0.87 PPARG (0.35) PPARGFFAR1RARGRXRACTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed